Amphastar (AMPH) Announces Clinical Trial Update
Amphastar (AMPH) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: potential, well
Diseases/Conditions: a differentiated safety profile
Collaboration: Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for
🔬 Clinical Development Pipeline (Amphastar):
Product
Type
Development Stage
Therapeutic Area
Source
Placebo-HFA
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Albuterol Sulfate (Provenetil-HFA)
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
albuterol (Armstrong Albuterol HFA)
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
HFA placebo
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
albuterol HFA (Proventil HFA)
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
albuterol HFA (Armstrong's)
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Albuterol Sulfate Inhalation Aerosol
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Armstrong Albuterol Sulfate Inhalation Aerosol
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Arm C-Epinephrine Inhalation Aerosol CFC
DRUG
Phase PHASE1
Asthma
ClinicalTrials.gov
Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation
DRUG
Phase PHASE1
Asthma
ClinicalTrials.gov
epinephrine inhalation aerosol
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Placebo
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Epinephrine HFA-MDI (E004)
DRUG
Phase PHASE3
Asthma
ClinicalTrials.gov
Arm C: Primatene Mist (epinephrine inhalation aerosol, USP)
📋 Amphastar (AMPH) - Clinical Trial Update
Filing Date: 2026-01-12
Accepted: 2026-01-12 17:15:07
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (Amphastar):
💼 Business Developments:
Structured Data: